Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. APLM
APLM logo

APLM

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

APLM News

Apollomics Narrows H1 Loss to $12.56M Amid Revenue Growth

Dec 23 2025NASDAQ.COM

Apollomics Reports 64% Reduction in Net Loss to $12.5 Million for H1 2025

Dec 22 2025Globenewswire

Apollomics Reveals Updates to Board of Directors and Committee Structure

Nov 18 2025Yahoo Finance

Lucas GC Shares Surge Over 36%; Check Out 20 Stocks Making Moves in Premarket Trading

Nov 03 2025Benzinga

Apollomics Confirms Ongoing Nasdaq Listing After Hearing Cancellation

Oct 15 2025Newsfilter

Nasdaq Suspends Trading of Apollomics Inc., Ltd.

Sep 17 2025Globenewswire

What's Behind The Big Stock Moves? BDSX, APLM, RNAZ...

May 21 2025NASDAQ.COM

Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress

Apr 03 2025Newsfilter

Apollomics and LaunXP Announce Development and Commercialization Agreement for Vebreltinib

Mar 31 2025Newsfilter

Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Dec 20 2024Newsfilter

Apollomics Meets Nasdaq Compliance On Bid Price Requirement

Dec 11 2024NASDAQ.COM

Apollomics Regains Compliance with Nasdaq's Minimum Bid Price Requirement

Dec 10 2024Newsfilter

Apollomics Inc trading halted, news pending

Nov 22 2024Business Insider

Apollomics' Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split

Nov 21 2024Newsfilter

Dow Dips Over 300 Points; Walmart Raises FY25 Forecast

Nov 19 2024Benzinga

Why Tesla Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Nov 18 2024Benzinga